 Osteoclastic inhibition action nitric cyclic GMP osteoclast unique ability bone excessive osteoclastic activity osteoporosis Paget disease bone rheumatoid arthritis growth metastases bone activity cell main circulating inhibitor calcitonin association modulators nitric oxide NO important member latter group vascular endothelium nervous system neurotransmission regulation blood pressure results autocoid potent inhibitor osteoclast function NO microM decrease original osteoclast spread area Similar effects sodium nitroprusside reagents NO shape changes reduction bone resorption incubation isolated osteoclasts devitalized bone slices NO guanylate cyclase consequent increase cyclic GMP different mode action likely osteoclast dibutyryl cyclic GMP effect calcitonin similar changes shape activity increase osteoclast intracellular calcium cessation membrane movement NO mode action different abundance NO-producing endothelial cells bone marrow proximity osteoclasts marrow endothelial cells physiological role regulation osteoclastic activity